Progress on Applying Carbon Dots for Inhibition of RNA Virus Infection

Yaung Kwee1, Yiqun Zhou2, Mochamad Zakki Fahmi3,4

  • 1Department of Chemistry, Pakokku University, Myaing Road, Pakokku 90401, Myanmar.

Nanotheranostics
|September 2, 2022
PubMed

Insights

Carbon dots (CDs) show promise as novel antiviral agents against emerging RNA viruses. This review summarizes their development for inhibiting viral infections and replication, with potential for in vivo applications.

Area of Science:

  • Nanotechnology
  • Virology
  • Materials Science

Background:

  • Viral infections pose a significant global health threat, with new lethal RNA viruses emerging annually.
  • Traditional antiviral drug development is time-consuming and costly, necessitating novel therapeutic strategies.
  • Carbon dots (CDs) have emerged as promising nanomaterials with versatile properties and significant antiviral potential.

Purpose of the Study:

  • To systematically review recent advancements in carbon dot-based antiviral therapies.
  • To explore the potential of carbon dots for inhibiting viral infection and replication.
  • To discuss the application of carbon dots in photodynamic inactivation of viruses and bacteria.

Main Methods:

  • Literature review of carbon dot applications in antiviral research.
  • Analysis of studies investigating carbon dots for inhibiting viral replication in vitro.
  • Exploration of emerging research on in vivo applications and photodynamic inactivation.

Main Results:

  • Carbon dots demonstrate broad-spectrum antiviral activity against various viruses in vitro.
  • Their versatile properties allow for diverse mechanisms of action, including direct inhibition and photodynamic inactivation.
  • Significant progress has been made in developing CDs as alternatives to traditional antiviral chemotherapy.

Conclusions:

  • Carbon dots represent a promising and rapidly developing field for novel antiviral therapies.
  • Further research into in vivo applications and safety profiles is crucial for clinical translation.
  • CDs offer a potential new avenue for combating viral infections and emerging viral threats.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
95